Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Shinya Osone"'
Autor:
Azusa Mayumi, Toshihiko Imamura, Hideki Yoshida, Shinya Osone, Takahiko Yasuda, Tomoko Iehara
Publikováno v:
eJHaem, Vol 4, Iss 3, Pp 751-755 (2023)
Abstract ETV6::Fyn‐related kinase (FRK), which is a Src family tyrosine‐kinase‐related fusion gene and firstly identified in our patient with paediatric high risk B cell precursor acute lymphoblastic leukaemia (B‐ALL), has no evidence of effi
Externí odkaz:
https://doaj.org/article/c7907b00617548f2ab519662195a4829
Autor:
Satoshi Sakaue, Takashi Kasai, Ikuko Mizuta, Masaya Suematsu, Shinya Osone, Yumiko Azuma, Toshihiko Imamura, Takahiko Tokuda, Hitoshi Kanno, Omar M. A. El-Agnaf, Masafumi Morimoto, Masanori Nakagawa, Hajime Hosoi, Toshiki Mizuno
Publikováno v:
npj Parkinson's Disease, Vol 3, Iss 1, Pp 1-3 (2017)
Early-onset Parkinson’s disease: a new genetic link Mutations in the gene encoding phosphoglycerate kinase 1 (PGK-1) may confer susceptibility to early-onset Parkinson’s disease (PD). PGK-1 is a crucial protein for the breakdown of sugar in the b
Externí odkaz:
https://doaj.org/article/15d3dd6eba764c9cb76b11aebe524a0b
Autor:
Sachiko Kawashima-Goto, Toshihiko Imamura, Chihiro Tomoyasu, Mio Yano, Hideki Yoshida, Atsushi Fujiki, Shinichi Tamura, Shinya Osone, Hiroyuki Ishida, Akira Morimoto, Hiroshi Kuroda, Hajime Hosoi
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0132926 (2015)
Early T-cell precursor-acute lymphoblastic leukemia (ETP-ALL) has been identified as a high-risk subtype of pediatric T-cell acute lymphoblastic leukemia (T-ALL). Conventional chemotherapy is not fully effective for this subtype of leukemia; therefor
Externí odkaz:
https://doaj.org/article/357df755938746a3b41c09752dac3b16
Autor:
Shinya Osone, Kunihiro Shinoda, Nobuyuki Yamamoto, Koji Suzuki, Michihiro Yano, Yuji Ishida, Yuya Saito, Akihisa Sawada, Hirozumi Sano, Yoko Kato, Yuichi Shinkoda, Mariko Kakazu, Naoko Mori, Shuki Mizutani, Keitaro Fukushima
Publikováno v:
International Journal of Clinical Oncology. 28:331-340
Preventing infection and managing febrile neutropenia (FN) is mandatory for children with cancer undergoing chemotherapy. However, the current situation in Japan is unknown.We conducted a nationwide web-based questionnaire survey in 153 institutions
Autor:
Kento Inoue, Satoshi Miyamoto, Dan Tomomasa, Eriko Adachi, Shohei Azumi, Yasuo Horikoshi, Takashi Ishihara, Shinya Osone, Yuta Kawahara, Ko Kudo, Zenichiro Kato, Hidenori Ohnishi, Kenichi Kashimada, Kohsuke Imai, Osamu Ohara, Menno C. van Zelm, Morton J. Cowan, Tomohiro Morio, Hirokazu Kanegane
Publikováno v:
Journal of Clinical Immunology. 43:585-594
Artemis is an exonuclease essential for V(D)J recombination and repair of DNA double-stranded breaks. Pathogenic variants in DCLRE1C encoding Artemis cause TClinical data of ART-SCID patients who were diagnosed between 2003 and 2022 in Japan were col
Autor:
Masaya, Suematsu, Shigeki, Yagyu, Hideki, Yoshida, Shinya, Osone, Yozo, Nakazawa, Kanji, Sugita, Toshihiko, Imamura, Tomoko, Iehara
Publikováno v:
Cancer Immunology, Immunotherapy. 72:957-968
CD19-specific chimeric antigen receptor T (CAR T) immunotherapy is used to treat B-cell malignancies. However, antigen-escape mediated relapse following CAR T therapy has emerged as a major concern. In some relapsed cases, especially KMT2A rearrangem
Autor:
Satoru Oya, Shinya Osone, Masanori Yoshida, Sota Nishimoto, Yoshihiro Taura, Hideki Yoshida, Mitsuru Miyachi, Tohru Inaba, Eiichi Konishi, Motohiro Kato, Toshihiko Imamura, Tomoko Iehara
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(9)
Erythroid sarcoma is very rare form of pure erythroid leukemia with undetermined biological features. Here, we present an infant with a multifocal erythroid sarcoma, diagnosed because the tumor cells were positive for glycophorin A. After acute myelo
Autor:
Hiroaki Kondo, Takuyo Kanayama, Utsuki Matsumura, Takayo Urata, Shinya Osone, Toshihiko Imamura, Tohru Inaba, Hajime Hosoi
A 7-year-old boy was diagnosed with RUNX1-RUNX1T1-positive acute myeloid leukemia. Although he achieved complete remission (CR) after conventional chemotherapy, he experienced relapse 6 months after completing initial treatment. The cytoplasm of myel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::022aafb45d1b271dd89d02ec9967082d
https://doi.org/10.22541/au.164864218.86270091/v1
https://doi.org/10.22541/au.164864218.86270091/v1
Autor:
Kenji, Okamoto, Shinya, Osone, Amane, Matsuura, Masamichi, Asazuma, Taro, Matsuoka, Takuyo, Kanayama, Toshihiko, Imamura, Hajime, Hosoi
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 63(1)
Post-transplant cyclophosphamide (PTCy) has improved the efficacy of HLA-mismatched hematopoietic cell transplantation (HCT) by decreasing the risk of graft-versus-host disease (GVHD) and nonrelapse mortality. If an HLA-matched donor is not available
Autor:
Tomomi Hayase, Makiko N Mieno, Kyoko Kobayashi, Naoko Mori, Adam Jon Lebowitz, Yoko Kato, Yuya Saito, Yuki Yuza, Hirozumi Sano, Shinya Osone, Tsukasa Hori, Yuichi Shinkoda, Nobuyuki Yamamoto, Daiichiro Hasegawa, Michihiro Yano, Miho Ashiarai, Daisuke Hasegawa, Akihisa Sawada, Takuhiro Yamaguchi, Akira Morimoto, Keitaro Fukushima
Publikováno v:
Journal of pain and symptom management. 63(5)
Few instruments in Japanese assess health-related quality of life in pediatric cancer patients.To translate the Memorial Symptom Assessment Scale (MSAS) into Japanese pediatric and proxy versions (MSAS-J 7-12, MSAS-J 13-18, and MSAS-J-Proxy) and asse